The House easily approved a sweeping biomedical bill Wednesday that would help drug and medical device companies win swifter government approval of their products, boost disease research and drug-abuse spending and revamp federal mental health programs.
The compromise, which envisions spending $6.3 billion over the next decade, was condemned by consumer groups and some Democrats as a present to drugmakers that promised only paltry spending increases for underfunded federal programs.
But their objections were overwhelmed by an alliance among Republicans, many Democrats and the White House for a 996-page measure that bore wins for both parties. The Senate’s expected final approval next week would mark an uncommon episode of cooperation between the GOP-run 114th Congress – which plans to adjourn next week – and President Barack Obama in their dwindling days in office.
Click here to Read the full article : House Passes Controversial Medical Funding ‘Cures’ Bill
Share this entry
- Protected: The American Health Council Appoints Dr. Ivory Gordon onto the Industry Board October 22, 2018
- Protected: The American Health Council appoints Mr. Peter Kiongo to the Occupational Therapy Board October 22, 2018
- Protected: The American Health Council appoints Dr. Nija Walker to the Industry Board October 22, 2018
- The American Health Council Welcomes Dr. Paolo Benito Andres to the Board of Occupational Therapy October 19, 2018
- The American Health Council Appoints Dr. Robert C. Hall, DPT, MS, BS to the Physical Therapy Board October 19, 2018
- The American Health Council Appoints Ms. Kodi Pride to Occupational Therapy Board October 18, 2018